04 / August / 2026 Researchers prefer AI for pre-submission article review Survey indicates that scientists view AI as an aid to improve manuscripts, but reject its adoption as a substitute for human peer review By Rodrigo de Oliveira Andrade
23 / July / 2026 AI fuels surge in manuscript submissions, increasing strain on peer review Analysis of nearly 7,000 manuscripts reveals a 42% increase in submissions and links intensive use of artificial intelligence to a declining quality of scientific writing By Rodrigo de Oliveira Andrade
22 / July / 2026 AI in education could become new “copy and paste” Study argues that educators should teach students to identify errors, cross-check sources, and question answers generated by artificial intelligence By Gabriela Monteiro
20 / July / 2026 Teaching faculty how to use ChatGPT is not enough, study warns Research suggests teacher training needs to go beyond tutorials and address ethics, methodologies, and new forms of AI-aided assessment By Gabriela Monteiro
16 / July / 2026 Can AI help overstretched peer reviewers? Researchers advocate using AI to screen manuscripts, detect fraud, and support editors, while warning of risks to process integrity By Daniel Dieb
10 / July / 2026 Cancer treatments advance, but clinical trials lack diversity Most drugs are tested on populations from wealthy countries—expanding participation to other regions could make therapies more effective for different patient profiles By Gabriela Monteiro
01 / July / 2026 El Niño 2026 raises concerns in Brazil Technical note predicts a high likelihood of the phenomenon developing in the second semester, putting extreme heat, droughts, flooding, and Brazil’s public health preparedness in the spotlight. By Bruno de Pierro
16 / June / 2026 Electroacupuncture may help treat chemotherapy-induced pain Phase 3 study presented at the ASCO Annual Meeting evaluates the technique as a nonpharmacological alternative for peripheral neuropathy in cancer patients By Samuel Antenor
12 / June / 2026 “An endangered species”: what is driving physician-scientists out of science? Survey of 230 US professionals finds that 49% are considering leaving research, for reasons beyond lack of funding By Gilberto Stam
10 / June / 2026 Cancer clinical trials grow more slowly than expected in Brazil, study finds A 20-year analysis shows that the country has made progress but still faces regulatory and cultural barriers, as well as reliance on the pharmaceutical industry. By Gabriela Monteiro
